NCT00005916View on ClinicalTrials.gov

PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 13, 2000

Study Completion Date

December 22, 2005

Conditions
Prostate CancerProstate Neoplasm
Interventions
DRUG

rV-PSA

DRUG

rF-PSA

DRUG

rV-B7.1

Trial Locations (1)

20892

National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00005916 - PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer | Biotech Hunter | Biotech Hunter